Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 2, 2013, Pages

  Martinez, Claudia A ^a,b   Singh, Vikas ^a   Heldman, Alan W ^a   O'Neill, William W ^a  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

aortic stenosis; Edwards SAPIEN; Impella 2.5; left ventricular assist device; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR THERAPEUTIC DEVICE; CASE REPORT; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; OPEN HEART SURGERY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE COMPLICATION; RETROGRADE LEFT VENTRICULAR SUPPORT; SHOCK; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC STENOSIS; EDWARDS SAPIEN; IMPELLA 2.5; LEFT VENTRICULAR ASSIST DEVICE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMERGENCIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; PROSTHESIS DESIGN; RADIOGRAPHY, INTERVENTIONAL; SHOCK; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84880596288     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24583     Document Type: Article

References (10)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
2. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-33.
3. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-98.
4. Mahapatra S, Bybee KA, Bunch TJ, et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005; 2: 907-11.
5. Navarrete CO, Marin F, Escriva AG, et al. Cardiac tamponade following pacemaker implantation. Int J Cardiol 2005; 104: 350-351.
6. Lange R, Bleiziffer S, Piazza N, et al. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg 2011; 40: 1105-1113.
7. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
8. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009; 2: 811-820.
9. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials. Eur Heart J 2009; 30: 2102-2108.
10. Scherner M, Madershahian N, Strauch JT, et al. Transapical valve implantation and resuscitation: risk of valve destruction. Ann Thorac Surg 2011; 92: 1909-1910.